CN Stock MarketDetailed Quotes

688192 Dizal Pharmaceutical

Watchlist
  • 52.23
  • -4.15-7.36%
Market Closed May 12 15:00 CST
24.00BMarket Cap-29.48P/E (TTM)

Dizal Pharmaceutical Key Stats

Dizal Pharmaceutical Q1 2025 Earnings Date

Currency:CNYApr 30, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
--
159.64M
--
+96.32%
EPS
--
-0.46
--
+14.81%
Strong Buy

May 12, 2025

Dizal Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 1.603B--
--2025/FY-- / 797.000M--
--2024/FY359.901M / 455.652M--
--2023/FY91.289M / 108.000M--
Mar 24, 20232022/FY0.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 1.603B--
--2025/FY-- / 797.000M--
--2024/FY359.901M / 455.652M--
--2023/FY91.289M / 108.000M--
Mar 24, 20232022/FY0.000 / 0.000--

Unlock Free Earnings Estimates

Dizal Pharmaceutical Earnings Reports

Read more

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More